MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma

Journal of Proteomics

Volumn 98, Issue , 2014, Pages 206-217

  Lee, Ju Yeon ^a,b   Kim, Jin Young ^a   Cheon, Mi Hee ^a,c   Park, Gun Wook ^a,c   Ahn, Yeong Hee ^a   Moon, Myeong Hee ^b   Yoo, Jong Shin ^a,c  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Yonsei University   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

Multiple reaction monitoring (MRM) validation; N glycoprotein; Nonglycosylated peptide; Rapid digestion; Undepleted plasma

Indexed keywords

BIOLOGICAL MARKER; CYSTEINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCAN; GLYCOPROTEIN; N GLYCOPROTEIN; OROSOMUCOID; PEPTIDE; TRYPSIN; TUMOR MARKER; UNCLASSIFIED DRUG; VITRONECTIN;

ARTICLE; DISULFIDE BOND; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; STEREOSPECIFICITY;

MULTIPLE REACTION MONITORING (MRM) VALIDATION; N-GLYCOPROTEIN; NONGLYCOSYLATED PEPTIDE; RAPID DIGESTION; UNDEPLETED PLASMA;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; PEPTIDES; PLASMA; PROTEOMICS; TRYPSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84893371597     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.01.003     Document Type: Article

References (60)

1. Lee J.Y., et al. Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma. Mol Cell Proteomics 2011, 10. [M111 009290]. 10.1074/mcp.M111.009290.
2. Parodi A.J. Protein glucosylation and its role in protein folding. Annu Rev Biochem 2000, 69:69-93. 10.1146/annurev.biochem.69.1.69.
3. Apweiler R., Hermjakob H., Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1999, 1473:4-8.
4. Ongay S., Boichenko A., Govorukhina N., Bischoff R. Glycopeptide enrichment and separation for protein glycosylation analysis. J Sep Sci 2012, 35:2341-2372. 10.1002/jssc.201200434.
5. Takahashi M., Kuroki Y., Ohtsubo K., Taniguchi N. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res 2009, 344:1387-1390. 10.1016/j.carres.2009.04.031.
6. Gu J., et al. A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. J Proteome Res 2009, 8:431-435. 10.1021/pr800674g.
7. Kim Y.S., et al. Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol Cell Proteomics 2008, 7:1-14. 10.1074/mcp.M700084-MCP200.
8. Drake P.M., et al. Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 2010, 56:223-236. 10.1373/clinchem.2009.136333.
9. de Leoz M.L., et al. High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics 2011, 10. [M110 002717]. 10.1074/mcp.M110.002717.
10. Kim Y.S., et al. Identification of target proteins of N-acetylglucosaminyl transferase V in human colon cancer and implications of protein tyrosine phosphatase kappa in enhanced cancer cell migration. Proteomics 2006, 6:1187-1191. 10.1002/pmic.200500400.
11. Hwang H., et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev 2010, 29:79-125. 10.1002/mas.20221.
12. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999, 9:67-81. 10.1006/scbi.1998.0119.
13. Moss E.L., Hollingworth J., Reynolds T.M. The role of CA125 in clinical practice. J Clin Pathol 2005, 58:308-312. 10.1136/jcp.2004.018077.
14. Meany D.L., Zhang Z., Sokoll L.J., Zhang H., Chan D.W. Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. J Proteome Res 2009, 8:613-619. 10.1021/pr8007539.
15. Wohlgemuth J., Karas M., Eichhorn T., Hendriks R., Andrecht S. Quantitative site-specific analysis of protein glycosylation by LC-MS using different glycopeptide-enrichment strategies. Anal Biochem 2009, 395:178-188. 10.1016/j.ab.2009.08.023.
16. Geyer H., Geyer R. Strategies for analysis of glycoprotein glycosylation. Biochim Biophys Acta 2006, 1764:1853-1869. 10.1016/j.bbapap.2006.10.007.
17. Boersema P.J., Geiger T., Wisniewski J.R., Mann M. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples. Mol Cell Proteomics 2012, 10.1074/mcp.M112.023614.
18. Madera M., Mechref Y., Novotny M.V. Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. Anal Chem 2005, 77:4081-4090. 10.1021/ac050222l.
19. Zielinska D.F., Gnad F., Wisniewski J.R., Mann M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 2010, 141:897-907. 10.1016/j.cell.2010.04.012.
20. Cao Z., et al. Modulation of glycan detection on specific glycoproteins by lectin multimerization. Anal Chem 2013, 85:1689-1698. 10.1021/ac302826a.
21. Li C., et al. A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer. Electrophoresis 2011, 32:2028-2035. 10.1002/elps.201000693.
22. Kim Y.S., et al. Lectin precipitation using phytohemagglutinin-L(4) coupled to avidin-agarose for serological biomarker discovery in colorectal cancer. Proteomics 2008, 8:3229-3235. 10.1002/pmic.200800034.
23. Wu J., Xie X., Nie S., Buckanovich R.J., Lubman D.M. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis. J Proteome Res 2013, 12:3342-3352. 10.1021/pr400169n.
24. Nie S., et al. Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry. Anal Chem 2013, 85:5353-5357. 10.1021/ac400838s.
25. Liu T., et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res 2005, 4:2070-2080. 10.1021/pr0502065.
26. Zhang H., Li X.J., Martin D.B., Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 2003, 21:660-666. 10.1038/nbt827.
27. Chen R., et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res 2009, 8:651-661. 10.1021/pr8008012.
28. Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res 2004, 3:556-566.
29. Wuhrer M., de Boer A.R., Deelder A.M. Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry. Mass Spectrom Rev 2009, 28:192-206. 10.1002/mas.20195.
30. Takegawa Y., et al. Profiling of N- and O-glycopeptides of erythropoietin by capillary zwitterionic type of hydrophilic interaction chromatography/electrospray ionization mass spectrometry. J Sep Sci 2008, 31:1585-1593. 10.1002/jssc.200700679.
31. Loftheim H., et al. 2-D hydrophilic interaction liquid chromatography-RP separation in urinary proteomics-minimizing variability through improved downstream workflow compatibility. J Sep Sci 2010, 33:864-872. 10.1002/jssc.200900554.
32. Neue K., Mormann M., Peter-Katalinic J., Pohlentz G. Elucidation of glycoprotein structures by unspecific proteolysis and direct nanoESI mass spectrometric analysis of ZIC-HILIC-enriched glycopeptides. J Proteome Res 2011, 10:2248-2260. 10.1021/pr101082c.
33. Jensen P.H., Mysling S., Hojrup P., Jensen O.N. Glycopeptide enrichment for MALDI-TOF mass spectrometry analysis by hydrophilic interaction liquid chromatography solid phase extraction (HILIC SPE). Methods Mol Biol 2013, 951:131-144. 10.1007/978-1-62703-146-2_10.
34. Zou Z., et al. Synthesis and evaluation of superparamagnetic silica particles for extraction of glycopeptides in the microtiter plate format. Anal Chem 2008, 80:1228-1234. 10.1021/ac701950h.
35. Larsen M.R., Jensen S.S., Jakobsen L.A., Heegaard N.H. Exploring the sialiome using titanium dioxide chromatography and mass spectrometry. Mol Cell Proteomics 2007, 6:1778-1787. 10.1074/mcp.M700086-MCP200.
36. Calvano C.D., Zambonin C.G., Jensen O.N. Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry. J Proteomics 2008, 71:304-317. 10.1016/j.jprot.2008.06.013.
37. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
38. Domanski D., et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 2012, 12:1222-1243. 10.1002/pmic.201100568.
39. Percy A.J., Chambers A.G., Yang J., Borchers C.H. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma. Proteomics 2013, 10.1002/pmic.201200316.
40. Percy A.J., Chambers A.G., Parker C.E., Borchers C.H. Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry. Methods Mol Biol 2013, 1000:167-189. 10.1007/978-1-62703-405-0_13.
41. Barnidge D.R., et al. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal Chem 2003, 75:445-451.
42. Albar J.P., Canals F. Standardization and quality control in proteomics. J Proteomics 2013, 95:1-2. 10.1016/j.jprot.2013.11.002.
43. Villanueva J., Carrascal M., Abian J. Isotope dilution mass spectrometry for absolute quantification in proteomics: concepts and strategies. J Proteomics 2013, 96C:184-199. 10.1016/j.jprot.2013.11.004.
44. Percy A.J., et al. Method and platform standardization in MRM-based quantitative plasma proteomics. J Proteomics 2013, 95:66-76. 10.1016/j.jprot.2013.07.026.
45. Jackson D., Bramwell D. Application of clinical assay quality control (QC) to multivariate proteomics data: a workflow exemplified by 2-DE QC. J Proteomics 2013, 95:22-37. 10.1016/j.jprot.2013.07.025.
46. Saito K., et al. Verification of protein disulfide bond arrangement by in-gel tryptic digestion under entirely neutral pH conditions. Proteomics 2010, 10:1505-1509. 10.1002/pmic.200900056.
47. Proc J.L., et al. A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. J Proteome Res 2010, 9:5422-5437. 10.1021/pr100656u.
48. Inuzuka S., et al. Vitronectin in liver disorders: biochemical and immunohistochemical studies. Hepatology 1992, 15:629-636.
49. Lee H.J., et al. Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens. J Proteome Res 2010, 9:308-318. 10.1021/pr900649b.
50. Chen R., et al. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol Cell Proteomics 2011, 10. [M110 006445]. 10.1074/mcp.M110.006445.
51. Kim K.A., et al. Diagnostic accuracy of serum asialo-alpha1-acid glycoprotein concentration for the differential diagnosis of liver cirrhosis and hepatocellular carcinoma. Clin Chim Acta 2006, 369:46-51. 10.1016/j.cca.2006.01.002.
52. Bachtiar I., et al. Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. Clin Chim Acta 2009, 399:97-101. 10.1016/j.cca.2008.09.024.
53. Lee E.Y., et al. Development of a rapid, immunochromatographic strip test for serum asialo alpha1-acid glycoprotein in patients with hepatic disease. J Immunol Methods 2006, 308:116-123. 10.1016/j.jim.2005.10.010.
54. Sano K., et al. Survival signals of hepatic stellate cells in liver regeneration are regulated by glycosylation changes in rat vitronectin, especially decreased sialylation. J Biol Chem 2010, 285:17301-17309. 10.1074/jbc.M109.077016.
55. Sano K., Asanuma-Date K., Arisaka F., Hattori S., Ogawa H. Changes in glycosylation of vitronectin modulate multimerization and collagen binding during liver regeneration. Glycobiology 2007, 17:784-794. 10.1093/glycob/cwm031.
56. Uchibori-Iwaki H., et al. The changes in glycosylation after partial hepatectomy enhance collagen binding of vitronectin in plasma. Glycobiology 2000, 10:865-874.
57. Anderson N., et al. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases. Biomed Chromatogr 2002, 16:365-372. 10.1002/bmc.167.
58. Sung H.J., et al. Large-scale isotype-specific quantification of serum amyloid A 1/2 by multiple reaction monitoring in crude sera. J Proteomics 2012, 75:2170-2180. 10.1016/j.jprot.2012.01.018.
59. Ahn Y.H., Shin P.M., Ji E.S., Kim H., Yoo J.S. A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometry. Anal Bioanal Chem 2012, 402:2101-2112. 10.1007/s00216-011-5646-3.
60. Kennedy J.J., et al. Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Nat Methods 2013, 10.1038/nmeth.2763.